SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001038133-22-000024
Filing Date
2022-05-09
Accepted
2022-05-09 12:09:13
Documents
88
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hska-20220331.htm   iXBRL 10-Q 1760803
2 EX-31.1 heska-03312022xex31x1.htm EX-31.1 11033
3 EX-31.2 heska-03312022xexx31x2.htm EX-31.2 10971
4 EX-32.1 heska-03312022xex32x1.htm EX-32.1 9562
10 LOGO hska-20220331_g1.jpg GRAPHIC 53004
  Complete submission text file 0001038133-22-000024.txt   9028675

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20220331.xsd EX-101.SCH 56889
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hska-20220331_cal.xml EX-101.CAL 106695
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hska-20220331_def.xml EX-101.DEF 331206
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hska-20220331_lab.xml EX-101.LAB 729812
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hska-20220331_pre.xml EX-101.PRE 491322
82 EXTRACTED XBRL INSTANCE DOCUMENT hska-20220331_htm.xml XML 1578806
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22427 | Film No.: 22903891
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences